ESSA Pharma Inc. Quarterly Income Tax Expense (Benefit) in USD from Q4 2019 to Q1 2023
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
ESSA Pharma Inc. annual/quarterly Income Tax Expense (Benefit) history and growth rate from Q4 2019 to Q1 2023.
- ESSA Pharma Inc. Income Tax Expense (Benefit) for the quarter ending March 31, 2023 was $1.6K.
- ESSA Pharma Inc. annual Income Tax Expense (Benefit) for 2023 was $1.6K.
- ESSA Pharma Inc. annual Income Tax Expense (Benefit) for 2022 was -$112K, a 226% decline from 2021.
- ESSA Pharma Inc. annual Income Tax Expense (Benefit) for 2021 was -$34.3K, a 88.1% increase from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)